Syneron to Present at Two Upcoming Conferences
13 Septiembre 2011 - 8:00AM
Marketwired
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic
device company, announced today that Louis P. Scafuri, Chief
Executive Officer, is scheduled to present at two upcoming investor
conferences. The first presentation will be at the annual UBS
Global Life Sciences Conference in New York City.
Event: UBS Global Life Sciences Conference
Date: Monday, September 19, 2011 Time: 9:30 a.m. ET
The second presentation will be at the JMP Securities Healthcare
Conference in New York City.
Event: JMP Securities Healthcare
Conference Date: Wednesday, September 28,
2011 Time: 10:00 a.m. ET
The presentations will be webcast live over the Internet and can
be accessed through the Investor Relations section on Syneron's
website at www.syneron.com. Please go to the website a few minutes
early, as it may be necessary to download audio software to hear
the presentation.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The Company markets and services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide. Additional information can be found at
www.syneron.com.
Contacts: Asaf Alperovitz Chief Financial Officer + 972
73 244 2283 Email: Email Contact Zack Kubow The Ruth Group
646-536-7020 Email: Email Contact
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024